Use of Fecal Microbiota for Transplantation Comes with Serious Risk, Says FDA

What's the news. The use of fecal microbiota for transplantation (FMT) to treat Clostridioides difficile comes with the risk for serious or life-threatening illnesses, the U.S. Food and Drug Administration (FDA) announced in a March 12, 2020, safety communication.